KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Net Margin (2016 - 2026)

Abbott Laboratories' Net Margin history spans 18 years, with the latest figure at 9.65% for Q1 2026.

  • On a quarterly basis, Net Margin fell 314.0% to 9.65% in Q1 2026 year-over-year; TTM through Mar 2026 was 13.91%, a 1798.0% decrease, with the full-year FY2025 number at 14.72%, down 1723.0% from a year prior.
  • Net Margin hit 9.65% in Q1 2026 for Abbott Laboratories, down from 15.5% in the prior quarter.
  • Over the last five years, Net Margin for ABT hit a ceiling of 84.1% in Q4 2024 and a floor of 9.65% in Q1 2026.
  • Historically, Net Margin has averaged 18.37% across 5 years, with a median of 14.16% in 2023.
  • Biggest five-year swings in Net Margin: soared 6853bps in 2024 and later crashed -6860bps in 2025.
  • Tracing ABT's Net Margin over 5 years: stood at 10.24% in 2022, then surged by 52bps to 15.56% in 2023, then soared by 440bps to 84.1% in 2024, then tumbled by -82bps to 15.5% in 2025, then plummeted by -38bps to 9.65% in 2026.
  • Business Quant data shows Net Margin for ABT at 9.65% in Q1 2026, 15.5% in Q4 2025, and 14.46% in Q3 2025.